Climb Bio, Inc. CLYM Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s operating cash flow?
- Climb Bio, Inc. (CLYM) reported operating cash flow of -$14.38M in Q1 2026.
- How has Climb Bio, Inc.'s operating cash flow changed year-over-year?
- Climb Bio, Inc.'s operating cash flow increased by 6.8% year-over-year, from -$15.43M to -$14.38M.
- What is the long-term trend for Climb Bio, Inc.'s operating cash flow?
- Over 3 years (2021 to 2025), Climb Bio, Inc.'s operating cash flow has grown at a 14.6% compound annual growth rate (CAGR), from -$36.07M to -$54.36M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.